Anthropic warns of ‘existential risks to humanity’ from AI; AstraZeneca makes $2bn cancer drug tie-up – business live
Anthropic, a leading artificial intelligence research company, has issued a stark warning regarding the potential existential risks posed by advanced AI systems to humanity.
The story
in brief.
What happened, who it affects, and why it landed on our intelligence desk — in plain English, sixty seconds or less.
Anthropic, a leading artificial intelligence research company, has issued a stark warning regarding the potential existential risks posed by advanced AI systems to humanity. Simultaneously, pharmaceutical giant AstraZeneca has announced a significant £2 billion partnership focused on developing new cancer treatments. These developments highlight the dual trajectory of the technology sector is currently pursuing: addressing profound ethical and safety concerns while aggressively driving commercial innovation in high-stakes industries like healthcare. The news underscores the urgent need for robust governance frameworks alongside rapid scientific advancement.
Indicative index of skill mentions in professional job postings for the field this story moves (2019 = 1)
What this means
for your career.
Every headline redistributes opportunity. Here is who this one rewards — and how to be on the right side of it.
This headline signals that AI safety and governance are no longer niche concerns but central business imperatives. You should prioritise skills in risk assessment and ethical framework development, as organisations increasingly seek professionals who can navigate these complex regulatory landscapes. For healthcare specialists, this deal confirms that AI-driven drug discovery is a critical growth area; you must understand how these technologies accelerate R&D pipelines. Smart professionals will immediately audit their current skill sets for gaps in compliance and strategic oversight. Consider upskilling in risk management to advise on AI deployment safely, or deepen your technical expertise in pharmaceutical AI applications. Proactively demonstrating competence in these areas will position you as indispensable in an era where technological advancement must be balanced with rigorous safety protocols and strategic business alignment.
For this story, the fields that convert it into pay are Risk Management, AI in Pharmaceuticals, AI Strategy and Healthcare Management — exactly the programmes matched below. The chart shows the indicative salary uplift certified professionals report in each of those fields; every one of them is a click away, from £79, finishing in as few as 20 days.
Indicative ranges from published continuing-education salary studies, by field — each field is a recommended course below
Enrol in these
to benefit.
These programmes position you for exactly this shift — online, self-paced, and finishing with a verifiable certificate you can share the day you pass.
Best match
Certificate in Risk Management
Recommended
Certificate in AI in Pharmaceuticals
Recommended
Certificate in AI Strategy
Recommended
Certificate in Healthcare Management
Launch pricing shown against standard certificate value. The fee you see today is the fee you lock in.
This briefing is based on reporting by The Guardian on 29 Sep, 06:41. Read the original coverage →
Read the news. Then outrun it.
Every LSBR programme is online, self-paced and from £79 — so a headline today can be your credential this month.